These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8884147)

  • 1. Tachyphylaxis to histamine-induced wheal suppression by topical 0.05% clobetasol propionate in normal versus croton oil-induced dermatitic skin.
    Singh S; Gupta A; Pandey SS; Singh G
    Dermatology; 1996; 193(2):121-3. PubMed ID: 8884147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tachyphylaxis to topical steroid measured by histamine-induced wheal suppression.
    Singh G; Singh PK
    Int J Dermatol; 1986 Jun; 25(5):324-6. PubMed ID: 3721670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reservoir effect of topical steroids in vitiliginous skin: A cross-sectional study.
    Singh SK; Nasir F
    Indian J Dermatol Venereol Leprol; 2015; 81(4):370-5. PubMed ID: 26144851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of reservoir effect of clobetasol propionate cream in an experimental animal model using histamine-induced wheal suppression test.
    Abidi A; Ahmad F; Singh SK; Kumar A
    Indian J Dermatol; 2010 Oct; 55(4):329-33. PubMed ID: 21430883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of reservoir effect of topical corticosteroids in an experimental animal model by histamine-induced wheal suppression test.
    Abidi A; Ahmad F; Singh SK; Kumar A
    Indian J Pharmacol; 2012; 44(6):722-5. PubMed ID: 23248401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of clobetasol propionate with varying dilutions of emollient determined by histamine wheal suppression test.
    Barathi M; Rai R; Srinivas CR
    Indian J Dermatol; 2011; 56(5):527-8. PubMed ID: 22121270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of topical corticosteroid application frequency on histamine-induced wheals.
    Narasimha SK; Srinivas CR; Mathew AC
    Int J Dermatol; 2005 May; 44(5):425-7. PubMed ID: 15869544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clobetasol propionate foam, 0.05%.
    Melian EB; Spencer CM; Jarvis B
    Am J Clin Dermatol; 2001; 2(2):89-92; discussion 93. PubMed ID: 11705308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Half an hour versus three hour contact of topical steroid (clobetasol propionate).
    Rai R; Uppal M; Sharma NK; Srinivas CR; Mathew A
    Indian J Dermatol Venereol Leprol; 2004; 70(4):214-6. PubMed ID: 17642617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Testing the loss of efficacy (tachyphylaxis) during external steroid application].
    Koch EM; Jurgovsky E
    Hautarzt; 1985 Mar; 36(3):146-9. PubMed ID: 3997512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by glucocorticoids of the mast cell-dependent weal and flare response in human skin in vivo.
    Cole ZA; Clough GF; Church MK
    Br J Pharmacol; 2001 Jan; 132(1):286-92. PubMed ID: 11156588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of topical steroid on the actions of vasoconstrictor and vasodilator peptides in human skin.
    Goldsmith P; Bunker C; Leslie T; Foreman J; Dowd PM
    Skin Pharmacol; 1996; 9(5):289-97. PubMed ID: 8990503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tachyphylaxis to Topical Therapy with Clobetasol Propionate.
    Singh PK
    Indian J Dermatol Venereol Leprol; 1989; 55(6):362-363. PubMed ID: 28128116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 0.05% clobetasol 17-propionate cream and ointment but not the corresponding 0.1% triamcinolone acetonide preparations increase skin surface roughness: a possible dissociation of unwanted epidermal and dermal effects.
    Kerscher MJ; Korting HC; Mehringer L; Mätzig R
    Skin Pharmacol; 1996; 9(2):120-3. PubMed ID: 8722606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic dermographism: wealing, mast cells and histamine are decreased in the skin following long-term application of a potent topical corticosteroid.
    Lawlor F; Black AK; Murdoch RD; Greaves MW
    Br J Dermatol; 1989 Nov; 121(5):629-34. PubMed ID: 2597634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of topically applied clobetasol-17-propionate on histamine release in human skin.
    Ståhle M; Hägermark O
    Acta Derm Venereol; 1984; 64(3):239-42. PubMed ID: 6204486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin atrophy induced by initial continuous topical application of clobetasol followed by intermittent application.
    Lubach D; Rath J; Kietzmann M
    Dermatology; 1995; 190(1):51-5. PubMed ID: 7894098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of vulval lichen sclerosus with a very potent topical steroid (clobetasol propionate 0.05%) cream.
    Dalziel KL; Millard PR; Wojnarowska F
    Br J Dermatol; 1991 May; 124(5):461-4. PubMed ID: 2039723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of clobetasol propionate emollient 0.05% in the treatment of patients with dry, scaly, corticosteroid-responsive dermatoses.
    Gordon ML
    Clin Ther; 1998; 20(1):26-39. PubMed ID: 9522102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the dermal immediate allergic reaction through prolonged treatment with topical glucocorticosteroids.
    Andersson M; Pipkorn U
    J Allergy Clin Immunol; 1987 Feb; 79(2):345-9. PubMed ID: 2434546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.